William B. Haas

Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC.

Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC.

CancerGuide Diagnostics was founded and launched by experienced individuals, passionate about fulfilling the unmet needs in current cancer care and drug development. CancerGuide Diagnostics'™ vision is to dramatically improve the management of cancer by providing physicians with advanced molecular diagnostics that enable individualized treatment decisions. CancerGuide is a singularly focused diagnostic product and services company that is actively licensing high-value, novel technology that may improve the quality of life for those living with cancer. Through its collaboration with Laboratory Corporation of America® Holdings (LabCorp®), CancerGuide provides an innovative development-to-commercial market platform for emerging molecular oncology diagnostic technologies. In addition to its internal diagnostic development programs, CancerGuide provides companion diagnostic development services, including tumor profiling and signature development services, to pharmaceutical and biotechnology companies to help maximize the efficiency and effectiveness of cancer therapy pipelines.

Plexigen, Inc. provided diagnostic equipment. The company was founded by Ben Hui Liu and is headquartered in Cary, NC.